 |
Verve Therapeutics
Last updated: July 30, 2024
Sekar Kathiresan, CEO
USA | Funding: $419.3M (+)
Website: https://www.vervetx.com/
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
Website: https://www.vervetx.com/
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
